Skip to main content
UK clinical trials - updated daily from ClinicalTrials.gov
TrialConnect
← Back to Search
UNKNOWNN/A

Visual Perception Difficulties After Stroke

Sponsor: Durham University

NCT ID: NCT05981482

View on ClinicalTrials.gov ↗

At a glance

What the study gets you
Health checks and monitoring — no treatment given
Type of study
Observational (no treatment given)
Time in hospital
In-person visits at study sites — visit count not specified by the sponsor
Drug or intervention
OxVPS (diagnostic test)
How long the study runs
Study runs about 32 months (dates as stated)
About the drug or intervention
OxVPS — diagnostic test: Comparing a new screening tool, the Oxford visual perception screening, to the gold standard, Rivermead Perceptual Battery Assessment.
Patient visit burden
Not specified by the sponsor
Type of study
Observing health over time
Ages
18 Years and over
Who
All
Number of participants
200
Started
2023-06-20
Last checked
2024-08

Plain English Summary

What is this study?

  • • Testing a new treatment for stroke
  • • Clinical study - 200 participants
  • • The goal of this observational study is to learn how well the Oxford Visual Perception Screening (OxVPS) tool can identify stroke survivors with visual perception difficulties

Who can take part?

  • • Ages 18 Years and over
  • • Diagnosed with stroke

Where?

  • • Abingdon - Abingdon Community Hospital
  • • Bishop Auckland - Bishop Auckland Hospital
  • • Gateshead - Queen Elizabeth Hospital

This is a simplified summary. Always discuss with your doctor before making any decisions.

About This Trial

The goal of this observational study is to learn how well the Oxford Visual Perception Screening (OxVPS) tool can identify stroke survivors with visual perception difficulties. The main aim is to determine the accuracy and utility of the OxVPS compared to the current gold standard assessment in stroke survivors. In other words, how well can the Oxford Visual Perception Screening tool (OxVPS) identify stroke patients with visual perception problems? Participants will completed the OxVPS and the current gold standards visual perception screening tool.

More detail

This is a non-experimental cross-sectional study. It aims to compare the new screening test OxVPS to the gold standard tests for visual perception difficulties. Patients will be recruited at stroke rehabilitation units at hospitals in the North East of England and in Oxfordshire. Following consent: * Participants will complete the paper version of the Oxford Visual Perception Screen OxVPS (\~15 min). * Participants will complete screening for visual perception problems with a validated screening tool (\~30-120 min). * Participants will complete screening for cognition alterations and sensory vision with validated screening tools. (\~30 min) * Stroke details (time since stroke, severity) and demographic data (age, socio-economic status) will be collected to evaluated representativeness of the sample.

StrokeVisual Perception

How this trial compares with your answers

Answer 2 more questions to improve match

What we know so far

Condition· Matched your search
Age· Tell us your age for better matching
Gender· Tell us your sex for better matching

Still need:

  • • Tell us your age for better matching
  • • Tell us your sex for better matching

Preliminary match based on your answers. Full eligibility requires on-site assessment including medical history, physical exam, and lab tests. This does not guarantee enrolment.

Eligibility at a Glance

Key info

  • Age: 18 Years and over
  • Who can join: All genders

What the study is looking for

  • ✓Patients with a clinical diagnosis of stroke (ischemic stroke and/or intracerebral haemorrhage).
  • ✓Within 6 weeks of confirmed stroke.

Who cannot take part

  • ✗Insufficient understanding of English
  • ✗Clinical concerns that patient is unable follow simple instructions.
  • ✗Clinical concerns that patient is unable to concentrate for 15 minutes.
  • ✗No capacity to provide agreement to take part.
See the full criteria
Inclusion Criteria: * Patients with a clinical diagnosis of stroke (ischemic stroke and/or intracerebral haemorrhage). * Within 6 weeks of confirmed stroke. Exclusion Criteria: * Insufficient understanding of English * Clinical concerns that patient is unable follow simple instructions. * Clinical concerns that patient is unable to concentrate for 15 minutes. * No capacity to provide informed consent.

Where Is This Study? (3 UK sites)

Abingdon Community Hospital

Abingdon OX14 1AG, United Kingdom

Recruiting
Site contact (verified)

Bishop Auckland Hospital

Bishop Auckland DL14 6AD, United Kingdom

Recruiting
Site contact (verified)
Revin Thomas, MDrevin.thomas@nhs.net

Queen Elizabeth Hospital

Gateshead NE9 6SX, United Kingdom

Recruiting
Site contact (verified)

How to Get in Touch

Kate Cowen, PhD

Sponsor contact

CONTACT

441913343275 kate.cowen@durham.ac.uk

Kathleen Vancleef, PhD

Sponsor contact

CONTACT

441913340108 kathleen.vancleef@durham.ac.uk
Data sourced from ClinicalTrials.gov · Last verified: 2024-08